BRAF and melanoma: Our data suggest that 22.1% of BRAF mutations in NZ melanomas were non-V600E mutations, which is similar to the 25% figure obtained in a study of 1,112 cases of melanoma using pyrosequencing or Sequenom MassARRAY [22].